Andrew Craig Miller insider trades

Open-market stock purchases and sales by Andrew Craig Miller, Director at Alto Neuroscience, Inc, from SEC Form 4 filings since Feb 14, 2020.

Recent trades

DateStockTradeValue
May 27, 2026ANRO Alto Neuroscience, IncBought (not open market)—
Feb 24, 2026KYTX Kyverna Therapeutics, IncBought (not open market)—
Feb 24, 2026KYTX Kyverna Therapeutics, IncBought (not open market)—

Companies traded

  • ANRO Alto Neuroscience, Inc: other filings, last May 27, 2026
  • KYTX Kyverna Therapeutics, Inc: other filings, last Feb 24, 2026
  • KRTX Karuna Therapeutics, Inc: 53 sales, last Mar 18, 2024

Get free alerts when Andrew Craig Miller files a new trade →